• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Rigel Finalizes Study Design of Fostamatinib Trial for Warm Autoimmune Hemolytic Anemia americanpharmaceuticalreview
    December 01, 2020
    Rigel Pharmaceuticals has reached agreement with the U.S. Food and Drug Administration (FDA) on the final design of its FORWARD study, a pivotal Phase 3 clinical trial of fostamatinib disodium hexahydrate (fostamatinib) in warm autoimmune hemolytic ...
  • Rigel Announces New Appointment to Board of Directors americanpharmaceuticalreview
    August 28, 2017
    Rigel Pharmaceuticals announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. Kotzin brings to Rigel's board three decades of experience in the areas of immunology and inflammation.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service